# US 2025/0082675 A1 · Trace element compositions, methods of making and use

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2025/0082675 A1
- Document ID: US20250082675A1
- Status: Published application
- Kind: A1
- Application number: 18/955,379
- Filed: 2024-11-21
- Published: 2025-03-13
- Earliest claimed: 2020-07-02
- Assignees: American Regent, Inc.
- Applicants: American Regent, Inc.
- Inventors: Gopal Anyarambhatla; Richard Lawrence; Jasmina Marinkovic
- Web page: https://patentgrep.com/patent/US20250082675A1

## CPC

- A61K 33/30: Zinc; Compounds thereof
- A61K 47/02: Inorganic compounds
- A61K 9/0029: {Parenteral nutrition; Parenteral nutrition compositions as drug carriers}
- A61K 31/7004: Monosaccharides having only carbon, hydrogen and oxygen atoms
- A61K 33/00: Medicinal preparations containing inorganic active ingredients
- A61K 33/04: Sulfur, selenium or tellurium; Compounds thereof
- A61K 33/06: Aluminium, calcium or magnesium; Compounds thereof {, e.g. clay}
- A61K 33/22: Boron compounds
- A61K 33/24: Heavy metals; Compounds thereof
- A61K 33/32: Manganese; Compounds thereof
- A61K 33/34: Copper; Compounds thereof
- A61K 47/10: Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A61K 47/20: containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids
- A61P 3/02: Nutrients, e.g. vitamins, minerals
- Y02A 50/30: Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- Y02A: TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE

## Abstract

Injectable compositions that can be added to parenteral nutrition are provided. In particular, a stable injectable composition is provided which includes water, and at least one of about 800 μg to about 4,000 μg of zinc, about 40 μg to about 400 μg of copper, from about 4 μg to about 90 μg of selenium, or from about 1 μg to about 80 μg of manganese per 1 mL of the injectable composition. Methods of preparing and using of the stable injectable composition are also provided.

## Claims

### Claim at position 1

-38. (canceled)

### Claim 39

A method of making an injectable composition, the method comprising mixing at least one of 800 μg to 4,000 μg of zinc, 40 μg to 400 μg of copper, 4 μg to 90 μg of selenium, or 1 μg to 80 μg of manganese with water to form 1 mL of the injectable composition, wherein the injectable composition has no chromium or chromium in an amount less than 1 μg per 1 mL of the injectable composition.

### Claim 40 (depends on 39)

The method of claim 39, wherein the injectable composition comprises 6 μg, 40 μg or 60 μg of selenium per 1 mL of the injectable composition.

### Claim 41

(canceled).

### Claim 42 (depends on 39)

The method of claim 39, wherein the zinc is elemental zinc, the copper is elemental copper, the selenium is elemental selenium, the manganese is elemental manganese and the water is sterile water for injection.

### Claim 43 (depends on 39)

The method of claim 39, wherein the composition has a pH of 1.2 to 5.

### Claim 44 (depends on 43)

The method of claim 43, wherein the composition further comprises at least sodium hydroxide, nitric acid or sulfuric acid to adjust the pH.

### Claim 45

(canceled)

### Claim 46 (depends on 39)

The method of claim 39, wherein the injectable composition is at least one of a preservative-free composition, a sterile composition, or a ready-to-use injectable aqueous composition.

### Claim 47 (depends on 39)

The method of claim 39, wherein the injectable composition comprises a preservative.

### Claim 48 (depends on 47)

The method of claim 47, wherein the preservative comprises benzyl alcohol in an amount of 0.9% by weight based on a total weight of the injectable composition.

### Claim 49 (depends on 42)

The method of claim 42, wherein the elemental zinc is from zinc sulfate or zinc sulfate heptahydrate, the elemental copper is from cupric sulfate or cupric sulfate pentahydrate, the elemental manganese is from manganese sulfate or manganese sulfate monohydrate and the elemental selenium is from selenious acid.

### Claim 50 (depends on 39)

The method of claim 39, wherein the injectable composition is in a multi-dose vial.

### Claim 51 (depends on 50)

The method of claim 50, wherein the multi-dose vial contains 10 mL of the injectable composition.

### Claim 52 (depends on 39)

The method of claim 39, wherein the injectable composition further comprises 0.00001 μg to 0.25 μg of chromium per 1 mL of the injectable composition.

### Claim 53 (depends on 39)

The method of claim 39, wherein the injectable composition contains 1 ppm to 6 μg of aluminum per 1 mL of the injectable composition.

### Claim 54 (depends on 39)

The method of claim 39, wherein the zinc is zinc sulfate heptahydrate at a dose of 2.5 to 7 mg/day, the copper is cupric sulfate pentahydrate at a dose of 0.5 to 1.5 mg/day, the manganese is manganese sulfate monohydrate at a dose of 0.15 to 0.8 mg/day, and the selenium is selenious acid at a dose of 20 to 40 μg/day.

### Claim at position 18

-75. (canceled)

### Claim 76 (depends on 39)

The method of claim 39, wherein the injectable composition is suitable for administration to an adult, pediatric or neonatal human patient when added to parenteral nutrition.

### Claim 77 (depends on 39)

The method of claim 39, wherein the injectable composition comprises chromium in an amount less than 1 μg per 1 mL of the injectable composition.

### Claim 78 (depends on 43)

The method of claim 43, wherein the injectable composition further comprises at least hydrochloric acid, hydrobromic acid, sulfuric acid, nitric acid, phosphoric acid, acetic acid, propionic acid, glycolic acid, pyruvic acid, oxalic acid, maleic acid, malonic acid, succinic acid, fumaric acid, tartaric acid, citric acid, benzoic acid, cinnamic acid, mandelic acid, methanesulfonic acid, ethanesulfonic acid, p-toluenesulfonic acid, salicylic acid, sodium hydroxide, potassium hydroxide, K2CO3, Na2CO3, K3PO4, Na3PO4, K2HPO4, or Na2HPO4 to adjust pH.

### Claim 79 (depends on 43)

The method of claim 43, wherein the injectable composition further comprises sulfuric acid to adjust pH.

### Claim 80 (depends on 43)

The method of claim 43, wherein the injectable composition further comprises nitric acid to adjust pH.
